Quantity and three-dimensional position of the recurrent and superior laryngeal nerve lower motor neurons in a rat model.
OBJECTIVE
We sought to elucidate the 3-dimensional position and quantify the lower motor neurons (LMNs) of the recurrent laryngeal nerve (RLN) and the superior laryngeal nerve (SLN) in a rat model. Quantification and mapping of these neurons will enhance the usefulness of the rat model in the study of reinnervation following trauma to these nerves.


METHODS
Female Sprague-Dawley rats underwent microsurgical transection of the RLN, the SLN, or both the RLN and SLN or sham surgery. After transection, either Fluoro-Ruby (FR) or Fluoro-Gold (FG) was applied to the proximal nerve stumps. The brain stems were harvested, sectioned, and examined for fluorolabeling. The LMNs were quantified, and their 3-dimensional position within the nucleus ambiguus was mapped.


RESULTS
Labeling of the RLN was consistent regardless of the labeling agent used. A mean of 243 LMNs was documented for the RLN. The SLN labeling with FR was consistent and showed a mean of 117 LMNs; however, FG proved to be highly variable in labeling the SLN. The SLN LMNs lie rostral and ventral to those of the RLN. In the sham surgical condition, FG was noted to contaminate adjacent tissues--in particular, in the region of the SLN.


CONCLUSIONS
Fluorolabeling is an effective tool to locate and quantify the LMNs of the RLN and SLN. The LMN positions and counts were consistent when FR was used in labeling of either the RLN or the SLN. Fluoro-Gold, however, because of its tendency to contaminate surrounding structures, can only be used to label the RLN. Also, as previously reported, the SLN LMNs lie rostral and ventral to those of the RLN. This information results in further clarification of a rat model of RLN injury that may be used to investigate the effects of neurotrophic factors on RLN reinnervation.
Department of Otolaryngology, New York Eye and Ear Infirmary, New York, NY 10003. USA.
Philip
P
Weissbrod
Michael J
MJ
Pitman
Sansar
S
Sharma
Aaron
A
Bender
Steven D
SD
Schaefer
D000818:Animals; D001933:Brain Stem / Q000473:pathology; D003911:Dextrans / Q000008:administration & dosage; D004195:Disease Models, Animal; D004576:Electromyography; D005260:Female; D005456:Fluorescent Dyes / Q000008:administration & dosage; D007821:Laryngeal Muscles / Q000294:innervation*; D061224:Laryngeal Nerve Injuries / Q000473:pathology; D007823:Laryngeal Nerves / Q000187:drug effects / Q000473:pathology* / Q000601:surgery; D051381:Rats; D017207:Rats, Sprague-Dawley; D061226:Recurrent Laryngeal Nerve Injuries / Q000473:pathology; D012235:Rhodamines / Q000008:administration & dosage; D013266:Stilbamidines / Q000008:administration & dosage
C049774:2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; D003911:Dextrans; D005456:Fluorescent Dyes; C067661:Fluoro-Ruby; D012235:Rhodamines; D013266:Stilbamidines